Impact of ABCB1 1236C > T-2677G > T-3435C > T polymorphisms on the anti-proliferative activity of imatinib, nilotinib, dasatinib and ponatinib
about
ABCB1 genetic variants in leukemias: current insights into treatment outcomesPharmacogenetics and Pharmacogenomics of Targeted Therapeutics in Chronic Myeloid Leukemia.The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia.Effect of ABCB1 genetic polymorphisms on the transport of rivaroxaban in HEK293 recombinant cell lines.Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study
P2860
Impact of ABCB1 1236C > T-2677G > T-3435C > T polymorphisms on the anti-proliferative activity of imatinib, nilotinib, dasatinib and ponatinib
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of ABCB1 1236C > T-2677 ...... tinib, dasatinib and ponatinib
@en
Impact of ABCB1 1236C > T-2677 ...... inib, dasatinib and ponatinib.
@nl
type
label
Impact of ABCB1 1236C > T-2677 ...... tinib, dasatinib and ponatinib
@en
Impact of ABCB1 1236C > T-2677 ...... inib, dasatinib and ponatinib.
@nl
prefLabel
Impact of ABCB1 1236C > T-2677 ...... tinib, dasatinib and ponatinib
@en
Impact of ABCB1 1236C > T-2677 ...... inib, dasatinib and ponatinib.
@nl
P2093
P2860
P356
P1433
P1476
Impact of ABCB1 1236C > T-2677 ...... tinib, dasatinib and ponatinib
@en
P2093
Géraldine Dessilly
Nadtha Panin
Vincent Haufroid
P2860
P2888
P356
10.1038/SREP29559
P407
P577
2016-07-12T00:00:00Z